Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012, European Journal of Cancer, vol.49, issue.6, pp.1374-403, 2013. ,
DOI : 10.1016/j.ejca.2012.12.027
Role of natural and adaptive immunity in renal cell carcinoma response to VEGFR-TKIs and mTOR inhibitor, International Journal of Cancer, vol.11, issue.12, pp.2772-2779, 2014. ,
DOI : 10.1002/ijc.28503
Differential Inhibition of Ex-Vivo Tumor Kinase Activity by Vemurafenib in BRAF(V600E) and BRAF Wild-Type Metastatic Malignant Melanoma, PLoS ONE, vol.18, issue.8, pp.1-12, 2013. ,
DOI : 10.1371/journal.pone.0072692.s006
Kinome Profiling in Pediatric Brain Tumors as a New Approach for Target Discovery, Cancer Research, vol.69, issue.14, pp.5987-95, 2009. ,
DOI : 10.1158/0008-5472.CAN-08-3660
Tumor phosphatidylinositol 3-kinase signaling in therapy resistance and metastatic dissemination of rectal cancer: Opportunities for signaling-adapted therapies, Critical Reviews in Oncology/Hematology, vol.95, issue.1, pp.114-138, 2015. ,
DOI : 10.1016/j.critrevonc.2015.01.003
Kinomic Profiling of Electromagnetic Navigational Bronchoscopy Specimens: A New Approach for Personalized Medicine, PLoS ONE, vol.41, issue.12, 2014. ,
DOI : 10.1371/journal.pone.0116388.s002
Prediction of Response to Preoperative Chemoradiotherapy in Rectal Cancer by Multiplex Kinase Activity Profiling, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.2, pp.555-62, 2010. ,
DOI : 10.1016/j.ijrobp.2010.04.036
High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes, PLOS ONE, vol.97, issue.16, 2015. ,
DOI : 10.1371/journal.pone.0139267.s006
The secret ally: immunostimulation by anticancer drugs, Nature Reviews Drug Discovery, vol.107, issue.3, pp.215-248, 2012. ,
DOI : 10.1038/nrd3626
The Effect of Sunitinib on Immune Subsets in Metastatic Clear Cell Renal Cancer, Urologia Internationalis, vol.86, issue.1, pp.53-62, 2011. ,
DOI : 10.1159/000319498
A Decrease of Regulatory T Cells Correlates With Overall Survival After Sunitinib-based Antiangiogenic Therapy in Metastatic Renal Cancer Patients, Journal of Immunotherapy, vol.33, issue.9, pp.991-999, 1997. ,
DOI : 10.1097/CJI.0b013e3181f4c208
Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans, Cytometry Part A, vol.341, pp.410-419, 2010. ,
DOI : 10.1002/cyto.a.20859
Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancer, Journal of Geriatric Oncology, vol.5, issue.2, pp.156-63, 2014. ,
DOI : 10.1016/j.jgo.2014.01.001
Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy, Eur Urol, vol.70, pp.358-64, 2016. ,
The Kinase Inhibitors Sunitinib and Sorafenib Differentially Affect NK Cell Antitumor Reactivity In Vitro, The Journal of Immunology, vol.183, issue.12, pp.8286-94, 1950. ,
DOI : 10.4049/jimmunol.0902404
Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma, Cancer Immunology, Immunotherapy, vol.211, issue.10, pp.1241-50, 2015. ,
DOI : 10.1007/s00262-015-1735-z
VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-KB-induced endothelial activation, FASEB J Off Publ Fed Am Soc Exp Biol, vol.29, pp.227-265, 2015. ,
Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-speci fi c immune responses and tumor eradication, OncoImmunology, vol.4, pp.1-11, 2015. ,
Diseaseassociated Expression Profiles in Peripheral Blood Mononuclear Cells from Patients with Advanced Renal Cell Carcinoma, Cancer Res, vol.63, pp.6069-75, 2003. ,
T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma, OncoImmunology, vol.1, issue.8, pp.1451-1454, 2012. ,
DOI : 10.1016/j.intimp.2010.07.002
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy, Cancer and Metastasis Reviews, vol.8, issue.Suppl 10, pp.83-95, 2011. ,
DOI : 10.1007/s10555-011-9281-4
T cells in tumors, The Journal of Experimental Medicine, vol.212, issue.2, pp.139-187, 2015. ,
DOI : 10.1002/ijc.26094
Circulating proteins as potential biomarkers of sunitinib and interferon-?? efficacy in treatment-na??ve patients with metastatic renal cell carcinoma, Cancer Chemotherapy and Pharmacology, vol.108, issue.2, pp.151-61, 2014. ,
DOI : 10.1007/s00280-013-2333-4
PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection, Cancer Immunology Research, vol.2, issue.4, pp.320-351, 2014. ,
DOI : 10.1158/2326-6066.CIR-13-0133
The Gracefully Aging Immune System, Science Translational Medicine, vol.5, issue.185, 2013. ,
DOI : 10.1126/scitranslmed.3005624
Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1 ,
Sunitinib: A VEGF and PDGF receptor protein kinase and angiogenesis inhibitor, Biochemical and Biophysical Research Communications, vol.356, issue.2, pp.323-331, 2007. ,
DOI : 10.1016/j.bbrc.2007.02.156
A quantitative analysis of kinase inhibitor selectivity, Nature Biotechnology, vol.50, issue.1, pp.127-159, 1038. ,
DOI : 10.1038/nbt1358
Sunitinib impairs the proliferation and function of human peripheral T cell and prevents T-cell-mediated immune response in mice, Clinical Immunology, vol.135, issue.1, pp.55-62, 2010. ,
DOI : 10.1016/j.clim.2009.11.013
Regulation of Src-family protein tyrosine kinase transcription during lymphocyte ontogeny, Molecular Immunology, vol.36, issue.15-16, pp.979-92, 1999. ,
DOI : 10.1016/S0161-5890(99)00134-0
Discoidin domain receptor 1 expression in activated T cells is regulated by the ERK MAP kinase signaling pathway, Journal of Cellular Biochemistry, vol.343, issue.12, pp.3666-74, 2011. ,
DOI : 10.1002/jcb.23300
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up??, Annals of Oncology, vol.25, issue.suppl 3, pp.49-56, 2014. ,
DOI : 10.1093/annonc/mdu259
Kinome Render: a stand-alone and web-accessible tool to annotate the human protein kinome tree, PeerJ, vol.41, issue.5600, pp.126-136, 2013. ,
DOI : 10.7717/peerj.126/supp-1